Open for business for less than a month and the site has now received 500 hits. Yes, I know that big name blogs receive that many or more in a day, but this is a new site and I'm pleased with traffic so far. I'll keep posting and you keep reading, adding your thoughts via comments or email. Thanks for your support!
To celebrate this meaningless number of 500 hits, feel free to subscribe to the site via email on the right.
skip to main |
skip to sidebar
Email
Psychiatric medications, science, marketing, psychiatry in general, and occasionally clinical psychology. Questioning the role of key opinion leaders and the use of "science" to promote commercial ends rather than the needs of people with mental health concerns.
Blog Archive
-
▼
2006
(219)
-
▼
October
(48)
- Burying Data, Chapter 214
- Patient Groups: Grassroots or Astroturf?
- Finally, a Debate!
- Restless Legs or Tireless Marketing: Requip
- Jane Pauley: Unwitting Spokesperson for Lilly?
- Big Pharma Tries to Sway the Election
- First Sperm Count, Now...
- Preventive Psychopharmacology? YIKES
- Post on Evidence Based Psychotherapies for Kids Up...
- Here's to Your Brain
- Is AstraZeneca in Trouble Over Seroquel?
- The Doctor is More Important than the Pill
- Do "Evidence Based" Psychotherapies Work Best for ...
- Prozac Lowers Sperm Count?
- Depakote for Mania: Small Beans
- Alzheimer's: Weed or Aricept?
- Cymbalta: Flooding the Market
- Forest: All Eggs in Two Psychiatric Baskets
- Lilly: Cymbalta and Zyprexa are Cash Cows
- Credible Source (?) on Paxil
- BusinessWeek Chimes In
- Put Your Creativity to Work
- More Unimpressive Results for Atypical Antipsychotics
- Zoloft for PMS: Impressive Statistical Gymnastics
- MHRA: It Just Keeps Coming
- Coming Soon...
- Generic Risperidone Coming Soon?
- Conflicted Conflict of Interest Policy at Stanford
- Yet Another Poor Showing for Atypical Antipsychotics
- War, What is it Good For... Part 2
- War, What it it Good For?
- Osteoporosis Training -- Sign up Now!
- Who’s Conducting Your Meta-Analysis?
- Switching From an Atypical to a Conventional Antip...
- Medicate First, Ask Questions Later?
- Big Pharma: Less Cash Toward Misinforming Doctors?
- Mo Pranksta Than Gangsta
- CPP Manifesto
- Check out Dr. Blumsohn's Latest
- Olanzapine and Diabetes
- If You're Looking for A Small Benefit -- Try Effex...
- The Future of Second Generation Antipsychotic Meds
- CUtLASS 1: Newer Antipsychotics Disappoint Again
- 500 Hits
- Upcoming Posts
- My Technorati Profile
- Pfizer: Treat Us Nice or Else We're Leaving!
- Yo Chuck, We Got Some Nonbelievers Out There (Corc...
-
▼
October
(48)
Academia
Pharma: General
Psychiatry and Psychology
Scientific Misconduct
About Me
- CL Psych
- I'm an academic with a respectable amount of clinical experience and no drug industry funding. Given my lack of time, don't expect multiple daily updates. Certain things about clinical psychology, the drug industry, psychiatry, and academics drive me nuts, and you'll probably pick up on these pet peeves before long...
Translate this page
Subscribe Via Email
No comments:
Post a Comment